Reshape Lifesciences Stock Filter Stocks by Fundamentals
RSLS Stock | USD 0.18 0.01 5.26% |
ReShape Lifesciences fundamentals help investors to digest information that contributes to ReShape Lifesciences' financial success or failures. It also enables traders to predict the movement of ReShape Stock. The fundamental analysis module provides a way to measure ReShape Lifesciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ReShape Lifesciences stock.
ReShape | Shares Owned by Institutions |
ReShape Lifesciences Institutional Holders
Institutional Holdings refers to the ownership stake in ReShape Lifesciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of ReShape Lifesciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing ReShape Lifesciences' value.Shares | Advisor Group Holdings, Inc. | 2023-12-31 | 5.0 | Group One Trading, Lp | 2023-12-31 | 3.0 | Ubs Group Ag | 2023-12-31 | 2.0 | Baader Bank Inc | 2023-12-31 | 0.0 | Renaissance Technologies Corp | 2023-12-31 | 0.0 | Morgan Stanley - Brokerage Accounts | 2023-09-30 | 0.0 | Cornerstone Planning Group Llc | 2023-12-31 | 0.0 | Jpmorgan Chase & Co | 2023-09-30 | 0.0 | Armistice Capital, Llc | 2023-12-31 | 0.0 | Two Sigma Securities, Llc | 2023-12-31 | 75.6 K | Virtu Financial Llc | 2023-12-31 | 73.5 K |
ReShape Fundamentals
Return On Equity | -2.18 | ||||
Return On Asset | -0.62 | ||||
Profit Margin | (2.67) % | ||||
Operating Margin | (1.44) % | ||||
Current Valuation | 3.09 M | ||||
Shares Outstanding | 23.46 M | ||||
Shares Owned By Insiders | 11.16 % | ||||
Shares Owned By Institutions | 1.96 % | ||||
Number Of Shares Shorted | 428.69 K | ||||
Price To Book | 1.38 X | ||||
Price To Sales | 0.43 X | ||||
Revenue | 9.81 M | ||||
Gross Profit | 6.8 M | ||||
EBITDA | (17.31 M) | ||||
Net Income | (26.16 M) | ||||
Cash And Equivalents | 11.49 M | ||||
Cash Per Share | 0.51 X | ||||
Total Debt | 171 K | ||||
Debt To Equity | 0.01 % | ||||
Current Ratio | 2.12 X | ||||
Book Value Per Share | 0.89 X | ||||
Cash Flow From Operations | (17.33 M) | ||||
Short Ratio | 1.15 X | ||||
Earnings Per Share | (38.56) X | ||||
Price To Earnings To Growth | (12.12) X | ||||
Target Price | 1.0 | ||||
Number Of Employees | 40 | ||||
Beta | 1.18 | ||||
Market Capitalization | 4.25 M | ||||
Total Asset | 11.14 M | ||||
Retained Earnings | (624.19 M) | ||||
Working Capital | 2.43 M | ||||
Z Score | -67.5 | ||||
Net Asset | 11.14 M |
About ReShape Lifesciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ReShape Lifesciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ReShape Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ReShape Lifesciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California. Reshape Lifesciences operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 47 people.
Currently Active Assets on Macroaxis
When determining whether ReShape Lifesciences is a strong investment it is important to analyze ReShape Lifesciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ReShape Lifesciences' future performance. For an informed investment choice regarding ReShape Stock, refer to the following important reports:Check out ReShape Lifesciences Piotroski F Score and ReShape Lifesciences Altman Z Score analysis. For more information on how to buy ReShape Stock please use our How to Invest in ReShape Lifesciences guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for ReShape Stock analysis
When running ReShape Lifesciences' price analysis, check to measure ReShape Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ReShape Lifesciences is operating at the current time. Most of ReShape Lifesciences' value examination focuses on studying past and present price action to predict the probability of ReShape Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ReShape Lifesciences' price. Additionally, you may evaluate how the addition of ReShape Lifesciences to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Stocks Directory Find actively traded stocks across global markets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Commodity Directory Find actively traded commodities issued by global exchanges |
Is ReShape Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ReShape Lifesciences. If investors know ReShape will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ReShape Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (38.56) | Revenue Per Share 4.399 | Quarterly Revenue Growth (0.23) | Return On Assets (0.62) | Return On Equity (2.18) |
The market value of ReShape Lifesciences is measured differently than its book value, which is the value of ReShape that is recorded on the company's balance sheet. Investors also form their own opinion of ReShape Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is ReShape Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ReShape Lifesciences' market value can be influenced by many factors that don't directly affect ReShape Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ReShape Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if ReShape Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ReShape Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.